2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
19
Completed
18
Recruiting
9
Not yet recruiting
6
Terminated
3
Withdrawn
2
Active not recruiting
2
Enrolling by invitation
1
Sponsor Class
OTHER
3
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Gastrointestinal
3
Conditions
Rectal Neoplasms
1
Esophageal Cancer Surgery
1
Colorectal Neoplasms
1
Interventions
Cyclophosphamide
391
Carboplatin
344
Gemcitabine
332
pembrolizumab
331
Cisplatin
328
Paclitaxel
298
Radiotherapy
297
Docetaxel
287
Bevacizumab
253
Rituximab
234
Capecitabine
224
Nivolumab
222
Dexamethasone
206
Fluorouracil
190
fludarabine
178
Oxaliplatin
177
Pemetrexed
153
Doxorubicin
153
Irinotecan
148
Leucovorin
144
Etoposide
144
Cytarabine
134
Cetuximab
130
fludarabine phosphate
129
Bortezomib
129
Lenalidomide
126
Filgrastim
120
Erlotinib Hydrochloride
120
Temozolomide
113
Radiosurgery
113
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Terminated
×
Preoperative Exercise
×
Clear all
NCT03876561
2026-04-20
CONTICARE
Nantes University Hospital
Phase NA
Terminated
120 enrolled
NCT03798951
2024-01-22
PRESS
Università Vita-Salute San Raffaele
Phase NA
Terminated
21 enrolled
NCT04097795
2023-12-18
PreColo CU
Radboud University Medical Center
Terminated
72 enrolled